Mutasynthesis Generates Nine New Pyrroindomycins

Zhuhua Wu,Zhengxiang Xia,Zhijun Tang,Ji’an Li,Wen Liu,Ji'an Li
DOI: https://doi.org/10.1039/d4ob00239c
2024-03-16
Organic & Biomolecular Chemistry
Abstract:Pyrroindomycins (PYRs) represent the only spirotetramate natural products discovered in nature, which possess potent activities against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Their unique structure and impressive biological activities make them an attractive target for synthesis and biosynthesis, however, the discovery and generation of new PYRs remains challengings. To date, only the initial components A and B have been reported. Herein, we report a mutasynthesis approach for the generation of nine new PYRs with varying acyl modifications on their deoxy-trisaccharide moiety. This was achieved by blocking the formation of acyl group 1,8-dihydropyrrolo[2,3-b]indole (DHPI) via the gene pyrK1 inactivation and supplying chemical acyl precursors. The gene pyrK1 encodes a DUF1864 family protein that probably catalyzes the oxidative transformation of L-tryptophan to DHPI, whose deletion results in the abolishment of DHPI-containing PYRs and the accumulation of three new PYRs either without acyl modification, or with DHPI replaced by benzoic acid and pyrrole-2-carboxylic acid. Capitalizing on the capacity of ΔpyrK1 mutant to produce new PYRs, we have successfully developed a mutasynthesis strategy for the generation of six novel PYR analogs with various aromatic acid modifications on their deoxy-trisaccharide moieties, showcasing the potential for generating structurally diverse PYRs. Overall, this research contributes significantly to understanding the biosynthesis of PYRs and offers valuable perspectives on their structural diversity.
chemistry, organic
What problem does this paper attempt to address?